DÄ internationalArchive14/2007Therapy and Prognosis of Bladder Cancer with Lymph Node Metastases

Review article

Therapy and Prognosis of Bladder Cancer with Lymph Node Metastases

Dtsch Arztebl 2007; 104(14): A-959

Stöckle, M; Lehmann, J; Krege, S; Gschwend, J E; Otto, T; Rübben, H

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

1. Leadbetter WF, Cooper JF: Regional gland dissection for carcinoma of the bladder: a technique for one-stage cystectomy, gland dissection and bilateral uretero-enterostomy. J Urol 1950; 63: 242–7. MEDLINE
2. Lehmann J, Retz M, Stöckle M, Hrsg.: Blasenkarzinom – Neue Perspektiven in Diagnostik und Behandlung. Heidelberg: Springer Medizin Verlag, 2005.
3. Smith JA, Whitmore WF: Regional lymph node metastasis from bladder cancer. J Urol 1981; 126: 591–3. MEDLINE
4. Skinner DG: Management of invasive bladder cancer: a meticulous pelvic node dissection can make a difference. J Urol 1982; 128: 34–6. MEDLINE
5. Stein JP, Cai J, Groshen S, Skinner DG: Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density. J Urol 2003; 170: 35–41. MEDLINE
6. Advanced Bladder Cancer Meta-Analysis Collaboration: Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol 2005; 48: 202–5. MEDLINE
7. Poulsen AL, Horn T, Steven K: Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol 1998; 160: 2015–9. MEDLINE
8. Leissner J, Hohenfellner R, Thüroff JW, Wolf HK: Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU Int 2000; 85: 817–23. MEDLINE
9. Herr HW: Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy. Urology 2003; 61: 105–8. MEDLINE
10. Stöckle M, Lehmann J: Therapie und Prognose des lymphogen metastasierten Urothelkarzinoms – Stellenwert der Lymphknotenchirurgie und der perioperativen systemischen Chemotherapie. In: Lehmann J, Retz M, Stöckle M: Blasenkarzinom – Neue Perspektiven in Diagnostik und Behandlung. Heidelberg: Springer 2005; 109–23.
11. Advanced Bladder Cancer Meta-Analysis Collaboration: Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data. Eur Urol 2005; 48: 189–99. MEDLINE
12. Lehmann J, Retz M, Wiemers C et al.: Adjuvant cisplatin plus methotrexate versus Methotrexate, vinblastine, epirubicin, and cisplatin in locally advanced bladder cancer: results of a randomized, multicenter, phase III trial (AUO-AB 05/95). J Clin Oncol 2005; 23: 4963–74. MEDLINE
13. Sternberg CN, de Mulder P, Schornagel JH et al.: Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours. Eur J Cancer 2006; 42: 50–4. MEDLINE
14. von der Maase H, Hansen SW, Roberts JT et al.: Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol 2000; 18: 3068–77. MEDLINE
15. Herr HW, Donat SM, Bajorin DF: Post-chemotherapy surgery in patients with unresectable or regionally metastatic bladder cancer. J Urol 2001; 165: 811–4. MEDLINE
16. Sweeney P, Millikan R, Donat M et al.: Is there a therapeutic role for post-chemotherapy retroperitoneal lymph node dissection in metastatic transitional cell carcinoma of the bladder? J Urol 2003; 169: 2113–7. MEDLINE
17. Hack M, Gerber M, Dilk O et al.: Long-term survival of patients with metastatic transitional cell carcinoma treated with a combined-modality approach of chemotherapy and metastasectomy. J Urol 2004; 171 Suppl.: 82.
18. Feinstein AR, Sosin DM, Wells CK: The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985; 312: 1604–8. MEDLINE

Info

Specialities